Srdjan Grusanovic

Srdjan Grusanovic

Auto-generated profile, based on publicly available information

Srdjan Grusanovic

Laboratory of Hemato-oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in EMBO Reports
Verified
Journal Article
Open access
SGSrdjan Grusanovic
Srdjan Grusanovic
PDPetr Danek
Petr Danek
MKMaria Kuzmina
Maria Kuzmina
MAMiroslava Kari Adamcová
Miroslava Kari Adamcová
MBMonika Burocziova
Monika Burocziova
MJMeritxell Alberich Jorda
Meritxell Alberich Jorda
Chronic inflammation represents a major threat to human health since long‐term systemic inflammation is known to affect distinct tissues and organs. Recently, solid evidence demonstrated that chronic inflammation affects hematopoiesis; however, how chronic inflammation affects hematopoietic stem cells (HSCs) on the mechanistic level is poorly understood. Here, we employ a mouse model of chronic multifocal osteomyelitis (CMO) to assess the effects of a spontaneously developed inflammatory condition on HSCs. We demonstrate that hematopoietic and nonhematopoietic compartments in CMO BM contribute to HSC expansion and impair their function. Remarkably, our results suggest that the typical features of murine multifocal osteomyelitis and the HSC phenotype are mechanistically decoupled. We show that the CMO environment imprints a myeloid gene signature and imposes a pro‐inflammatory profile on HSCs. We identify IL‐6 and the Jak/Stat3 signaling pathway as critical mediators. However, while IL‐6 and Stat3 blockage reduce HSC numbers in CMO mice, only inhibition of Stat3 activity significantly rescues their fitness. Our data emphasize the detrimental effects of chronic inflammation on stem cell function, opening new venues for treatment.

8 May 2026 in Science Advances
Verified
Journal Article
Open access
MKMaria Kuzmina
Maria Kuzmina
SGSrdjan Grusanovic
Srdjan Grusanovic
JBJiri Brezina
Jiri Brezina
FTFlavian Thelen
Flavian Thelen
KVKarolina Vanickova
Karolina Vanickova
MJMeritxell Alberich Jorda
Meritxell Alberich Jorda
Hematopoietic stem and progenitor cells (HSPCs) are localized within specialized niches of the bone marrow (BM). However, during hematological disorders or infections, the functionality of these cells in the BM is compromised, leading to extramedullary hematopoiesis (EMH). Chronic inflammation drives EMH, yet its impact on HSPCs outside the BM is poorly understood. Using a mouse model of chronic autoinflammatory disease, we demonstrated the presence of extramedullary HSPCs in blood, spleen, and inflamed tails and paws. Single-cell transcriptomics revealed a unique expression profile in extramedullary HSCs, with significant up-regulation of Cd53 , MHCII-associated, and immunosuppressive genes. We further demonstrated that extramedullary CD53 + HSPCs act as antigen-presenting cells, promoting the development of regulatory T cells (T reg cells) to control chronic inflammation at extramedullary sites. Conversely, T reg cells exert a protective role on extramedullary HSPCs. Together, our findings revealed a mutually supportive relationship between a unique subset of HSPCs and T cells in inflamed tissues during chronic inflammation.

8 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMaria Kuzmina
Maria Kuzmina
SGSrdjan Grusanovic
Srdjan Grusanovic
JBJiri Brezina
Jiri Brezina
MMMirko Milosevic
Mirko Milosevic
KVKarolina Vanickova
Karolina Vanickova
MJMeritxell Alberich Jorda
Meritxell Alberich Jorda
Hematopoietic stem cells (HSCs) are localized within specialized niches of the bone marrow (BM). However, during hematological disorders or infections, the functionality of HSCs in the BM is compromised, leading to extramedullary hematopoiesis (EMH). Chronic inflammation drives EMH, yet its impact on HSCs outside the BM is poorly understood. Using a mouse model of chronic autoinflammatory disease, we demonstrated the presence of extramedullary HSCs in blood, spleen, and inflamed tails and paws. Single-cell transcriptomics revealed a unique expression profile in extramedullary HSCs, with significant upregulation of Cd53 , MHCII-associated, and immunosuppressive genes. We further demonstrated that extramedullary CD53+ HSCs act as antigen-presenting cells, promoting the development of regulatory T cells (Tregs) to control chronic inflammation at extramedullary sites. Conversely, Tregs exert a protective role on extramedullary HSCs. Altogether, our findings revealed a mutually supportive relationship between a unique subset of HSCs and T cells in inflamed tissues during chronic inflammation.